Bm Potassium Iodide (kali Iod)
Generic Name: bm potassium iodide (kali iod)
Brand Names:
Bm Potassium Iodide (kali Iod) 6x
Uses See the leaflet enclosed for detail.
Overview
Uses See the leaflet enclosed for detail.
Uses
Uses See the leaflet enclosed for detail.
Dosage
Directions: Adult: Four tablets three times a day. Ages below 12: half of the same or as prescribed by a homeopathic physician.
Warnings
Warnings and Storage: Ask a professional before use if pregnant or breastfeeding or if you have severe symptoms. Keep away from children. If you have a reaction to this product that is not positive, discontinue use. Store in a cool and dry place.
Frequently Asked Questions
What is Bm Potassium Iodide (kali Iod) used for?▼
Uses See the leaflet enclosed for detail.
What are the important warnings for Bm Potassium Iodide (kali Iod)?▼
Warnings and Storage: Ask a professional before use if pregnant or breastfeeding or if you have severe symptoms. Keep away from children. If you have a reaction to this product that is not positive, discontinue use. Store in a cool and dry place.
Related Medications
Esketamine Hydrochloride
esketamine hydrochloride
11 DESCRIPTION SPRAVATO ® contains esketamine hydrochloride, a non-competitive N -methyl- D -aspartate (NMDA) receptor antagonist. Esketamine is the S-enantiomer of racemic ketamine. The chemical name is (S) -2-(o-chlorophenyl)-2-(methylamino)cyclohexanone hydrochloride. Its molecular formula is C 13 H 16 ClNO.HCl and its molecular weight is 274.2.
Tobramycin Ophthalmic Solution
tobramycin ophthalmic solution
Aminoglycoside Antibacterial [EPC]
DESCRIPTION Tobramycin ophthalmic solution USP, 0.3% is a sterile topical ophthalmic antibiotic formulation prepared specifically for topical therapy of external ophthalmic infections. Each mL of Tobramycin Ophthalmic Solution USP contains: Active : tobramycin 0.3% (3 mg). Preservative : benzalkonium chloride 0.01% (0.1 mg). Inactives : boric acid, sodium sulfate decahydrate, sodium chloride, tyloxapol, sodium hydroxide and/or sulfuric acid (to adjust pH) and water for injection.
Brimonidine
brimonidine
11 DESCRIPTION Brimonidine Topical Gel, 0.33% contains brimonidine tartrate, an alpha adrenergic agonist. The molecular formula of brimonidine tartrate is C 11 H 10 BrN 5 • C 4 H 6 O 6 . It has the following structural formula: Chemically, brimonidine tartrate is 5-Bromo-6-(2-imidazolidinylideneamino) quinoxaline L-tartrate. Brimonidine tartrate has a molecular weight of 442.24 and appears as white to slightly yellowish powder.
Medical Disclaimer
This drug information is for educational purposes only and should not replace professional medical advice. Drug information is sourced from the FDA National Drug Code Directory and Structured Product Labeling. Always consult with a healthcare provider before starting, stopping, or changing any medication.